← Leaderboards
Lori Sakoda
Kaiser Foundation Research Institute
$4,805,191
Attributed
$8,807,974
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,807,974 · 6
By mechanism
R01$5,554,245 · 4
UG1$2,333,610 · 1
K07$920,119 · 1
Top collaborators
- Charles Stewart Kamen3 shared
- Jeffrey Kuang Zou Lee3 shared
- Quyen Ngo-Metzger2 shared
- Song Yao2 shared
- Florian J. Fintelmann1 shared
- Rebecca Elizabeth Graff1 shared
- Theresa E Hahn1 shared
- Louise Henderson1 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Lawrence H Kushi$60,993,337
- Erin Elizabeth Hahn$7,456,765
- Nikki Carroll$909,145
- Bette J Caan$23,657,335
- Song Yao$11,329,919
Others in their field
Top investigators on “Follow-Up”
- Jeffrey P Krischer · University Of South Florida$398,381,597
- James Dennis Neaton · Northwestern University$283,212,546
- Gregory H Reaman · National Childhood Cancer Foundation$201,951,987
- Judith S Hochman · New York University School Of Medicine$125,409,158
- Mark R Farfel · Hugo W. Moser Res Inst Kennedy Krieger$119,981,780
- David R. Weir · University Of Michigan At Ann Arbor$119,885,186
Research focus
Follow-UpEnrollmentAdultDiagnosisMalignant Neoplasm Of LungRaceScreening For CancerScreeningElectronic Health RecordCaliforniaEligibility DeterminationMortalitySurveysSmokingMalignant NeoplasmsRecording Of Previous EventsResourcesSmoking HistoryEarly DiagnosisCohortSmoking CessationRecommendationCancer DetectionTumor
Grant awards (17)
OPTimizing surveillance in lung cancer survivors with novel IMAging biomarkers and deep-Learning (OPTIMAL)$968,999
R01 · FY2025 · CA
Multi-Cancer Early Detection and Screening (MED SCREEN) Study$894,340
UG1 · FY2025 · CA
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors$766,294
R01 · FY2025 · CA
Vanguard Study Administrative Supplement$581,000
UG1 · FY2025 · CA
Multilevel Determinants of Differences in Lung Cancer Screening Utilization$549,580
R01 · FY2025 · CA · contact PI
Multi-Ethnic Multi-Cancer Early Detection and Screening (MED SCREEN) Study$858,270
UG1 · FY2024 · CA
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors$735,428
R01 · FY2024 · CA
Multilevel Determinants of Racial/Ethnic Disparities in Lung Cancer Screening Utilization$8,149
R01 · FY2024 · CA · contact PI
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors$815,928
R01 · FY2023 · CA
Multilevel Determinants of Racial/Ethnic Disparities in Lung Cancer Screening Utilization$536,775
R01 · FY2023 · CA · contact PI
Multilevel Determinants of Racial/Ethnic Disparities in Lung Cancer Screening Utilization$643,926
R01 · FY2022 · CA · contact PI
Genome-wide Pleiotropy Scan across Multiple Cancers$529,166
R01 · FY2019 · CA
Evaluating a Risk Prediction Model for Lung Cancer$149,359
K07 · FY2019 · CA · contact PI
Evaluating a Risk Prediction Model for Lung Cancer$192,864
K07 · FY2018 · CA · contact PI
Evaluating a Risk Prediction Model for Lung Cancer$192,744
K07 · FY2017 · CA · contact PI
Evaluating a Risk Prediction Model for Lung Cancer$192,384
K07 · FY2016 · CA · contact PI
Evaluating a Risk Prediction Model for Lung Cancer$192,768
K07 · FY2015 · CA · contact PI